This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Moll, R. Articles by Sun, T. T. Search for Related Content PubMed PubMed Citation Articles by Moll, R. Articles by Sun, T. T.

American Journal of Pathology, Vol 147, 1383-1397, Copyright © 1995 by American Society for Investigative Pathology

REGULAR ARTICLES

Uroplakins, specific membrane proteins of urothelial umbrella cells, as histological markers of metastatic transitional cell carcinomas

R Moll, XR Wu, JH Lin and TT Sun
Institutes of Pathology, University of Mainz Medical School, Germany.

Uroplakins (UPs) Ia, Ib, II, and III, transmembrane proteins constituting the asymmetrical unit membrane of urothelial umbrella cells, are the first specific urothelial differentiation markers described. We investigated the presence and localization patterns of UPs in various human carcinomas by applying immunohistochemistry (avidin-biotin-peroxidase complex method), using rabbit antibodies against UPs II and III, to paraffin sections. Positive reactions for UP III (sometimes very focal) were noted in 14 of the 16 papillary noninvasive transitional cell carcinomas (TCCs) (88%), 29 of the 55 invasive TCCs (53%), and 23 of the 35 TCC metastases (66%). Different localization patterns of UPs could be distinguished, including superficial membrane staining like that found in normal umbrella cells (in papillary carcinoma), luminal (microluminal) membrane staining (in papillary and invasive carcinoma), and, against expectations, peripheral membrane staining (in invasive carcinoma). Non-TCC carcinomas of various origins (n = 177) were consistently negative for UPs. The presence of UPs in metastatic TCCs represents a prime example of even advanced tumor progression being compatible with the (focal) expression of highly specialized differentiation repertoires. Although of only medium-grade sensitivity, UPs do seem to be highly specific urothelial lineage markers, thus operating up interesting histodiagnostic possibilities in cases of carcinoma metastases of uncertain origin.

This article has been cited by other articles:

				M.-T. Sung, S. Zhang, G. T. MacLennan, A. Lopez-Beltran, R. Montironi, M. Wang, P.-H. Tan, and L. Cheng Histogenesis of Clear Cell Adenocarcinoma in the Urinary Tract: Evidence of Urothelial Origin Clin. Cancer Res., April 1, 2008; 14(7): 1947 - 1955. [Abstract] [Full Text] [PDF]

				S.-M. Lee, E.-J. Lee, H.-Y. Hong, M.-K. Kwon, T.-H. Kwon, J.-Y. Choi, R.-W. Park, T.-G. Kwon, E.-S. Yoo, G.-S. Yoon, et al. Targeting Bladder Tumor Cells In vivo and in the Urine with a Peptide Identified by Phage Display Mol. Cancer Res., January 1, 2007; 5(1): 11 - 19. [Abstract] [Full Text] [PDF]

				F. Lopez-Rios, S. Chuai, R. Flores, S. Shimizu, T. Ohno, K. Wakahara, P. B. Illei, S. Hussain, L. Krug, M. F. Zakowski, et al. Global Gene Expression Profiling of Pleural Mesotheliomas: Overexpression of Aurora Kinases and P16/CDKN2A Deletion as Prognostic Factors and Critical Evaluation of Microarray-Based Prognostic Prediction. Cancer Res., March 15, 2006; 66(6): 2970 - 2979. [Abstract] [Full Text] [PDF]

				L. Mo, J. Cheng, E. Y.-H. P. Lee, T.-T. Sun, and X.-R. Wu Gene deletion in urothelium by specific expression of Cre recombinase Am J Physiol Renal Physiol, September 1, 2005; 289(3): F562 - F568. [Abstract] [Full Text] [PDF]

				S. Signoretti, M. M. Pires, M. Lindauer, J. W. Horner, C. Grisanzio, S. Dhar, P. Majumder, F. McKeon, P. W. Kantoff, W. R. Sellers, et al. p63 regulates commitment to the prostate cell lineage PNAS, August 9, 2005; 102(32): 11355 - 11360. [Abstract] [Full Text] [PDF]

				F. Koga, S. Kawakami, Y. Fujii, K. Saito, Y. Ohtsuka, A. Iwai, N. Ando, T. Takizawa, Y. Kageyama, and K. Kihara Impaired p63 Expression Associates with Poor Prognosis and Uroplakin III Expression in Invasive Urothelial Carcinoma of the Bladder Clin. Cancer Res., November 15, 2003; 9(15): 5501 - 5507. [Abstract] [Full Text] [PDF]

				J. A. Ramos-Vara, M. A. Miller, M. Boucher, A. Roudabush, and G. C. Johnson Immunohistochemical Detection of Uroplakin III, Cytokeratin 7, and Cytokeratin 20 in Canine Urothelial Tumors Vet. Pathol., January 1, 2003; 40(1): 55 - 62. [Abstract] [Full Text] [PDF]

				J. Zhang, N. Ramesh, Y. Chen, Y. Li, J. Dilley, P. Working, and D.-C. Yu Identification of Human Uroplakin II Promoter and Its Use in the Construction of CG8840, a Urothelium-specific Adenovirus Variant That Eliminates Established Bladder Tumors in Combination with Docetaxel Cancer Res., July 1, 2002; 62(13): 3743 - 3750. [Abstract] [Full Text] [PDF]

				V. Ambrosio, G. Borzacchiello, F. Bruno, P. Galati, and F. Roperto Uroplakin Expression in the Urothelial Tumors of Cows Vet. Pathol., November 1, 2001; 38(6): 657 - 660. [Abstract] [Full Text] [PDF]

				K. Ogawa, S. L. Johansson, and S. M. Cohen Immunohistochemical Analysis of Uroplakins, Urothelial Specific Proteins, in Ovarian Brenner Tumors, Normal Tissues, and Benign and Neoplastic Lesions of the Female Genital Tract Am. J. Pathol., October 1, 1999; 155(4): 1047 - 1050. [Abstract] [Full Text] [PDF]

				Z.-T. Zhang, J. Pak, E. Shapiro, T.-T. Sun, and X.-R. Wu Urothelium-specific Expression of an Oncogene in Transgenic Mice Induced the Formation of Carcinoma in Situ and Invasive Transitional Cell Carcinoma Cancer Res., July 1, 1999; 59(14): 3512 - 3517. [Abstract] [Full Text] [PDF]

				S. T. Truschel, W. G. Ruiz, T. Shulman, J. Pilewski, T.-T. Sun, M. L. Zeidel, and G. Apodaca Primary Uroepithelial Cultures. A MODEL SYSTEM TO ANALYZE UMBRELLA CELL BARRIER FUNCTION J. Biol. Chem., May 21, 1999; 274(21): 15020 - 15029. [Abstract] [Full Text] [PDF]